Capvizr
News · All summaries
Healthcare & Life Sciences
Thryv Therapeutics
Series B$30 million
RoundSeries B
Amount$30 million
LeadInClin
HQMontreal, Canada
DateNovember 3, 2026
THE DEAL, AT A GLANCE

Thryv Therapeutics

From the announcement
Who is involvedBacked by InClinFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedThryv Therapeutics raised $30M Series B, announced 2026-11-03From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Thryv Therapeutics · Financing Record

Explore source-linked visual explanations for Thryv Therapeutics. Unsupported claims are withheld while source review continues.

Record 15218 · Recorded date: 2026-11-03

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime